Skin Cancer

A two-time cancer survivor suggests simplifying the holidays when coping with cancer.

One expert discusses exciting advances in using drug combinations to treat metastatic melanoma.

Two-time cancer survivor gratefully shares her gratitude and discusses how they are getting better at helping cancer patients.

Two-time cancer survivor reviews some of the questions about genetic testing for other cancer survivors.

The overall survival rate in patients with melanoma has increased exponentially in the past decade. But thanks to the use of combinations in the treatment of melanoma, the future looks even brighter, according to one expert from the Melanoma Institute Australia.

A melanoma expert addresses the findings of two studies on the disease in children, adolescents and young adults, and shares ways in which they can protect themselves.

I have to admit I think about death a lot more since my two cancers, and I think that is OK.

A two-time, nine-year cancer survivor offers some suggestions to newly diagnosed cancer survivors.

A two-time cancer survivor shares the good that eventually came from her cancer experiences.

Here’s a sneak peek at what’s inside our Fall 2019 issue.

New therapies address difficult- to-treat advanced squamous cell carcinoma of the skin.

A two-time cancer survivor learns more about pancreatic cysts and discusses the value and cautions of genetic testing.

Cutaneous squamous cell carcinoma, caused by sun exposure or environmental toxins, is usually curable with surgery. Maybe that’s why many don’t realize that, if this cancer goes unchecked and untreated, it can grow, spread and become life-threatening.

A cancer survivor and clutter-clearing author shares autumnal time management tips.

One in two patients with metastatic melanoma is alive five years following treatment with Opdivo plus Yervoy, according to long-term follow-up of the phase 3 CheckMate 067 trial.